Posts

Stovall Award sq Logo Bl Ribbon

NCCS to Recognize Julia H. Rowland, PhD and Tom Smith, MD with 2020 Ellen L. Stovall Award

/in /by

Stovall AwardNCCS is pleased to announce the 2020 winners of the Ellen L. Stovall Award for Innovation in Patient-Centered Cancer Care are Julia H. Rowland, PhD and Thomas J. Smith, MD. They will be recognized at the 2020 Virtual Stovall Award Reception on Wednesday, November 18 at 7:00 p.m. ET.

The esteemed selection committee chose from among a highly qualified group of nominees who embody the essence of the award and Ellen’s passion and advocacy for patient-centered cancer care. Dr. Rowland and Dr. Smith are experts in their fields who are continuing to enhance the lives of cancer survivors in our country.

And now, for the first time ever, we invite you to attend the virtual awards ceremony to recognize the importance of these innovative pioneers. Please register for the event and invite colleagues, friends, and family.

 

Meet the Awardees

Julia H. Rowland, PhD

Julia H. Rowland, PhD“Across her career as a clinician, researcher, and teacher in the area of psychosocial aspects of cancer, Dr. Rowland has promoted patient-centeredness, engaged patients, families, and caregivers to inform the process of improving the delivery of quality cancer care and collaborated effectively with others to improve quality within the cancer care system.”

— Deborah K. Mayer, PhD, RN, AOCN, FAAN
Frances Hill Fox Distinguished Professor
Director of Cancer Survivorship
UNC Lineberger Comprehensive Cancer Center

Julia H. Rowland, PhD is a long-time clinician, researcher, and teacher in the area of psychosocial aspects of cancer. She has worked with and conducted competitively funded research among both pediatric and adult cancer survivors, and published broadly in psycho-oncology.

She was recruited to the National Cancer Institute (NCI) to become the first, full-time Director of the Office of Cancer Survivorship (OCS). After 18 years in this role, Dr. Rowland retired from service at the NCI in September 2017 and assumed the role of Senior Strategic Advisor at Smith Center for Healing and the Arts, a small non-profit organization that has been providing integrative support services to cancer patients and their families for over twenty years.

Thomas J. Smith, MD

Thomas J. Smith, MD“Dr. Smith provides total and compassionate care to improve the quality of life of all suffering from their illness. He creates a calm environment which is unhurried, allowing the patient to be empowered to have critical conversations. Dr. Smith has taught hundreds how to improve their own skills and thereby the quality of care they deliver.”

— Patrick J. Coyne, MSN, ACHPN, ACNS-BC, FAAN, FPCN
Palliative Care Director
Medical University of South Carolina

Thomas J. Smith, M.D., is a professor of oncology at the Johns Hopkins University School of Medicine, director of Palliative Medicine for Johns Hopkins Medicine and the Harry J. Duffey Family Professor of Palliative Care. He is a medical oncologist and a palliative care specialist with a lifelong interest in better symptom management, communication, and improving access to high quality affordable care. Dr. Smith began Johns Hopkins’ hospital-wide palliative care consult service as well as an inpatient unit, and he is dedicated to accelerating palliative care research and education.

Dr. Smith is also a prostate cancer survivor, experiencing first hand surgery, recurrence, “salvage” radiation therapy and androgen deprivation therapy with many significant side effects. He knows all too well the experience of living and working while waiting for the other shoe to drop.

Ellen L. Stovall Award Reception Details

The honorees will be recognized at the Virtual Stovall Award Reception on Wednesday, November 18. The award presentation is open to the public and will feature videos highlighting the honorees and their work.

Wednesday, November 18, 2020 at 7:00 p.m. ET

 
REGISTER FOR THE VIRTUAL STOVALL AWARD RECEPTION » 

American Society of Clinical OncologyThe Stovall Award is given annually to two recipients who have improved the care and lives of cancer survivors and their families — one health care provider and one patient advocate or advocacy organization. The health care provider award is co-presented by the American Society of Clinical Oncology.
# # #
2019 Stovall Award Honorees Brereton and Dornsife and presenters

NCCS Presents 4th Annual Ellen L. Stovall Award to Dr. Harmar Brereton and Dana Dornsife for Their Innovation and Dedication to Cancer Survivors

/in , , , , , /by
Stovall Award Honorees Harmar Brereton and Dana Dornsife with presenters

From left to right: Rep. Matt Cartwright, Dr. Harmar Brereton, NCCS CEO Shelley Fuld Nasso, Dana Dornsife, Rep. Mark DeSaulnier, Sen. Bob Casey. (Photo: Leslie E. Kossoff/LK Photos)

Washington, D.C. – The National Coalition for Cancer Survivorship (NCCS) presented the 4th annual Ellen L. Stovall Award for Innovation in Patient-Centered Cancer Care to Dr. Harmar Brereton and Dana Dornsife on November 13.

Named for former NCCS CEO Ellen Stovall, who died in 2016 due to complications from three cancer treatments, the award highlights those who continue Ellen’s work of transforming cancer care to further incorporate patients’ goals, needs, and values. Sen. Robert Casey (PA) and Congressman Matt Cartwright (PA-8) joined NCCS to present the award to their constituent, Dr. Brereton, and Congressman Mark DeSaulnier (CA-11), a cancer survivor, presented the award to his constituent, Mrs. Dornsife.

“The Stovall Awards reception is a highlight of our year, as we honor Ellen’s legacy of advocating for everyone touched by cancer to have access to the best cancer care possible, during and after their cancer treatment. This year’s honorees exemplify her life’s work and passion: Dr. Harmar Brereton was her physician and friend, and is a compassionate, patient-centered oncologist and teacher, and Dana Dornsife has dedicated herself to ensuring that cancer patients have access to clinical trials for their treatment and to advance the science,” said Shelley Fuld Nasso, NCCS CEO.

Sen. Bob Casey and Rep. Matt Cartwright present the 2019 Stovall Award to their constituent Harmar Brereton, MD.

Sen. Bob Casey (Left) and Rep. Matt Cartwright (Right) present the 2019 Stovall Award to their constituent Harmar Brereton, MD. (Photo: Leslie E. Kossoff/LK Photos)

Dr. Brereton spent thirty-three years in private practice and founded the Northeast Regional Cancer Institute in his community of Scranton, Pennsylvania. He teaches at the Weill Cornell School of Medicine and is on the faculty of the Geisinger Commonwealth School of Medicine, formerly the Commonwealth Medical College, a school he helped found. He is also a leadership team member of the International Cancer Expert Corps. Dr. Brereton is a graduate of Yale University and earned a medical degree from the University of Pittsburgh. He trained in Internal Medicine at Emory University, Medical Oncology and Hematology at the NCI, and Radiation Oncology at Johns Hopkins University.

Sen. Bob Casey said of Dr. Brereton, “Two words that come to mind, not describing a doctor, but describing a human being: uncommon decency.”

“Dr. Brereton has not only transformed cancer care in our region, but he continues to change the culture of cancer care everywhere as he teaches and guides the next generation of providers about true patient-centered care,” said Rep. Matt Cartwright.

Dr. Brereton reflected on his drive to serve patients: “These long-term relationships we have with patients require humility. However, it is also these long-term relationships that for me have been so important in shaping and reaffirming my conviction of trying to meet my patient’s needs.” He continued, “We honor our cancer patients by remembering them, and by telling their stories.”

Rep. Mark DeSaulnier presents the 2019 Stovall Award to his constituent Dana Dornsife.

Rep. Mark DeSaulnier presents the 2019 Stovall Award to his constituent Dana Dornsife. (Photo: Leslie E. Kossoff/LK Photos)

Dana Dornsife is Chair of the Board and Founder of Lazarex Cancer Foundation, a nationwide non-profit organization she created in 2006. The unique mission of Lazarex is to improve the outcome of cancer care—giving hope, dignity, and life to advanced stage cancer patients and the medically underserved by providing assistance with costs for FDA clinical trial participation, identification of clinical trial options, community outreach and engagement. Mrs. Dornsife expanded the mission at Lazarex to bring transformational change to the bench to bedside process of clinical trial enrollment, retention, minority participation and equitable access with IMPACT (IMproving Patient Access to Cancer Clinical Trials). She is a graduate of Drexel University in Philadelphia and serves as a board member of the USC Brain and Creativity Institute at University of Southern California, the UCSF Cancer Leadership Council, and the MGH Presidents Council.

Rep. Mark DeSaulnier commented, “Dana’s an example of somebody who was about to lose a family member whom she loved, at an age where you wouldn’t expect to. And she did what we would all think that we would do. She dropped everything to make sure that her sister had every ounce of her energy, affection, and love. And then she transferred that, not just to her sister, but all of us.”

In her remarks, Mrs. Dornsife said, “I am honored and I am humbled to be a recipient of the Ellen Stovall award, an award that really is a testament to [Ellen’s] pioneering and transformational work on behalf of all cancer patients. And although I’m standing here and I’m the named recipient of this award, I would not be here if it wasn’t for all of the treasured people in my life who’ve been critical in advancing the Lazarex Cancer Foundation mission.”

Read more about Dana Dornsife, Dr. Brereton, and the Ellen L. Stovall Award »

Make a gift to the Stovall Award program »

# # #

Related Posts

NCCS Presents 3rd Annual Ellen L. Stovall Award to Gay Crawford and Dr. Norman Coleman, Their 40+ Year Careers Focused on Improving Patient-Centered Cancer Care

NCCS’ Ellen L. Stovall Award Reception Recognizes Two Individuals Advancing Patient-Centered Cancer Care

NCCS Presents the Inaugural Ellen Stovall Award to Douglas W. Blayney, MD, FACP (Video)

Stovall Award sq Logo Bl Ribbon

NCCS Announces 2019 Stovall Award Honorees, Dr. Harmar Brereton and Dana Dornsife

/in , , , /by
Ellen L. Stovall Award for Innovation in Patient-Centered Cancer CareThe National Coalition for Cancer Survivorship (NCCS) is pleased to announce that the 2019 winners of the Ellen L. Stovall Award for Innovation in Patient-Centered Cancer Care are Harmar Brereton, MD, founder of the Northeast Regional Cancer Institute, and Dana Dornsife, founder and board chair of the Lazarex Cancer Foundation.

Now in its fourth year, the cancer community’s embrace of the award named after longtime NCCS CEO Ellen Stovall continues to be a testament to her lasting influence. Through years of perseverance and dedication, Ellen was instrumental in improving cancer care delivery for millions of Americans. Her warm personality and infectious drive to create change fueled a movement of collaboration throughout the cancer community to advance cancer care and cancer survivorship. After she died in 2016 due to cardiac complications from her cancer treatment, NCCS created the Stovall Award to honor her memory, carry on her legacy, and ensure the momentum she helped foster continues to benefit patients.

NCCS presents the Stovall Award annually to individuals, organizations, or other entities that are finding innovative ways to improve cancer care. The number, diversity, and quality of this year’s nominations was impressive and showed the passion that advocates and providers have to improve care for patients. We are grateful for the time and dedication of our esteemed selection committee, comprised of cancer survivors, advocates, and health care providers, and the leadership of co-chair Dr. Doug Blayney.

Harmar Brereton, MD
Harmar Brereton, MD
“Perhaps one of the most impactful collaborations in Dr. Brereton’s extraordinary career remains his early work and long friendship with Ellen Stovall. Through him, and in turn through the thousands of lives he has touched, Ellen’s work continues, and her mission lives on.”

— Karen M. Saunders, President, Northeast Regional Cancer Institute

Dana Dornsife
Dana Dornsife
“Patient reimbursements and engagement are key, and Ms. Dornsife had the vision to understand that and the leadership to make it happen. Lazarex provides a key to hope… a key to life. I cherish every moment with my grandkids and my daughters, and I get that opportunity because of Dana Dornsife.”

— Jackie Hinckley, Stage 4 Metastatic Breast Cancer Patient

About the Honorees

Harmar Brereton, MD

Dr. Brereton is a graduate from Yale University and earned a medical degree from the University of Pittsburgh. Subsequent training in Internal Medicine took him to Emory University in Atlanta, Georgia. Dr. Brereton spent the next six years at the National Cancer Institute doing clinical and basic research and obtained certification in both Medical Oncology and Hematology. He completed additional training at Johns Hopkins for Radiation Oncology and was board certified.

Dr. Brereton served on the staff at Georgetown University for two years and then entered private practice where he spent thirty-three years developing cancer services by founding the Northeast Regional Cancer Institute in his community of Scranton, Pennsylvania. At the end of his private practice career, he was involved in the development of a new school, The Commonwealth Medical College, now the Geisinger Commonwealth School of Medicine, where he continues to serve on the faculty as a Clinical Professor of Medicine. In addition to also teaching at the Weill Cornell School of Medicine, he is also a leadership team member of the International Cancer Expert Corps.

Dana Dornsife

Dana Dornsife is Chair of the Board and Founder of Lazarex Cancer Foundation, a nationwide public non-profit organization she began in 2006. The unique mission of Lazarex is to improve the outcome of cancer care—giving hope, dignity, and life to advanced stage cancer patients and the medically underserved by providing assistance with costs for FDA clinical trial participation, identification of clinical trial options, community outreach and engagement.

Dana has recently expanded the mission at Lazarex to bring transformational change to the bench to bedside process of clinical trial enrollment, retention, minority participation and equitable access with IMPACT (IMproving Patient Access to Cancer Clinical Trials). She is a graduate of Drexel University in Philadelphia and serves as a board member of the USC Brain and Creativity Institute at University of Southern California, the UCSF Cancer Leadership Council, and the MGH Presidents Council.

Ellen L. Stovall Award Reception Details

The honorees will be recognized at the Stovall Award Reception in Washington, D.C. on Wednesday, November 13. The award presentation will feature videos highlighting the honorees and their work.

Stovall Award Reception

Wednesday, November 13, 2019

6:30 PM — 8:30 PM

Four Seasons Hotel
Washington, DC

Save to Outlook/Apple Calendar »

Save to Google Calendar »

For sponsorship and ticket information, please click here or call us at 301.650.9127.

Related Posts

https://www.canceradvocacy.org/nccs-news/nccs-3rd-annual-stovall-award-gay-crawford-dr-norman-coleman/
https://www.canceradvocacy.org/nccs-news/nccs-ellen-l-stovall-award-reception-recognizes-two-individuals-advancing-patient-centered-cancer-care/

https://www.canceradvocacy.org/blog/nccs-presents-inaugural-ellen-stovall-award-douglas-w-blayney-md/

2018 Stovall Award presentation

NCCS Presents 3rd Annual Ellen L. Stovall Award to Gay Crawford and Dr. Norman Coleman, Their 40+ Year Careers Focused on Improving Patient-Centered Cancer Care

/in , , , /by

From left to right: Rep. Jamie Raskin, Rep. Debbie Wasserman Schultz, Dr. Norman Coleman, Gay Crawford, Rep. Anna Eshoo, NCCS CEO Shelley Fuld Nasso. (Photo by Leslie E. Kossoff/LK Photos)

Washington, D.C. – The National Coalition for Cancer Survivorship (NCCS) hosted the 3rd annual Ellen L. Stovall Award for Innovation in Patient-Centered Cancer Care reception. Named for former NCCS CEO, Ellen Stovall, who died in 2016 due to complications from three cancer treatments, the award seeks to highlight those who continue Ellen’s work of transforming cancer care to further incorporate patients’ goals, needs, and values. This year’s honorees are Gay Crawford, founding director of Cancer CAREpoint, and Dr. Norman Coleman, senior investigator at the National Cancer Institute.

NCCS was honored to be joined by three Members of Congress. Rep. Anna Eshoo (CA-18) introduced and presented the award to her constituent, Gay Crawford. Rep. Jamie Raskin (MD-8), a cancer survivor, introduced and presented the award to his constituent, Dr. Norman Coleman. Rep. Debbie Wasserman Schultz (FL-23), also a cancer survivor, shared opening remarks about her cancer journey and why patient-centered care is so important.

“Once again, we have two exceptional leaders in Gay Crawford and Dr. Norman Coleman as this year’s honorees of the Ellen Stovall Award,” said NCCS CEO Shelley Fuld Nasso. “For more than forty years, they each have used their experience and expertise to improve the lives of so many who face a cancer diagnosis. They are each incredibly impressive individuals for what they have done for patients in their careers and are highly deserving of this recognition.”

Since her diagnosis of breast cancer at age 30, Gay Crawford spent the last 44 years playing a major leadership role in bringing more complete patient-focused cancer care to the Silicon Valley area. She’s helped found and lead numerous organizations, culminating in the non-profit organization Cancer CAREPoint, providing a wide-range of cancer support services to anyone in Silicon Valley free of charge.

“Since 1974 and my first cancer diagnosis, I realized that there must be a better way to help patients navigate and ultimately improve the experience of a cancer journey,” said Gay Crawford. “Knowing that patient-focused care and advocacy at the personal and legislative level can make a real difference is a driving force that remains with me today. It is an honor to be recognized with the Ellen Stovall Award.”

Dr. Norman Coleman is board certified in internal medicine, medical oncology, and radiation oncology. He was a professor at Stanford University School of Medicine and Harvard Medical School, before returning to the National Cancer Institute to serve as director of the Radiation Oncology Sciences Program. He continues to lead a laboratory at NCI focusing on radiation-induced molecular and immunotherapy targets. He is also a Senior Medical Advisor in the Office of Emergency Management, and the Senior Scientific Advisor to the International Cancer Expert Corps (ICEC), a non-government organization focusing on global disparities in cancer care.

“I met Ellen Stovall many years ago and our shared interest and understanding of innovative patient-centered cancer care delivery forged a tremendous friendship,” said Dr. Norman Coleman. “Since early in my career and in every role that I serve, I always ask myself, ‘is this what the patient wants and is it in their best interest?’ Having known Ellen and worked with her over the years, I want to thank NCCS for this recognition and I appreciate being part of their present and future efforts to bring quality cancer care to the many in need. This award and collaboration mean so much to me.”

Read more about Gay Crawford, Dr. Norman Coleman, and the Ellen L. Stovall Award »

Read about Ellen’s life of advocacy »

# # #

Watch Videos About the Stovall Award Honorees

[embedyt] https://www.youtube.com/watch?v=L-Kc3HZ8HZQ&width=1089&height=612[/embedyt] 
[embedyt] https://www.youtube.com/watch?v=0eDnzs7V1YA&width=1089&height=612[/embedyt]

Related Posts

NCCS’ Ellen L. Stovall Award Reception Recognizes Two Individuals Advancing Patient-Centered Cancer Care

NCCS Presents the Inaugural Ellen Stovall Award to Douglas W. Blayney, MD, FACP (Video)

Stovall Award sq Logo Bl Ribbon

NCCS Announces Winners of the 2018 Ellen L. Stovall Award for Innovation in Patient-Centered Cancer Care

/in , , /by
Longtime NCCS CEO Ellen Stovall made a lasting impact on the cancer community, both personally and professionally, through her warmth, generosity, and spirit of collaboration as she worked to make cancer care better for all patients. Shortly after she died in 2016 due to cardiac complications from her cancer treatment, the National Coalition for Cancer Survivorship (NCCS) created the Ellen L. Stovall Award for Innovation in Patient-Centered Cancer Care to honor her memory and help carry on her legacy. The Stovall Award is given annually to individuals, organizations, or other entities that are finding innovative ways to improve cancer care.

Ellen’s influence continues to be felt, as we saw the response and interest in this award grow yet again this year. We had an outstanding number of quality nominations and are grateful for the dedication of our esteemed selection committee, including the leadership of co-chair Dr. Doug Blayney, who had the difficult task of choosing the winners.

After careful and considerable deliberation by the committee, we are excited to announce that the 2018 Stovall Award winners are Dr. Norman Coleman and Gay Crawford.

2018 Stovall Award Honorees

About the Honorees

Dr. Coleman, a radiation oncologist, is a leading provider advocate for patient-centeredness; emphasizing access to care, respect for patient preferences, and coordination and integration of care. For more than 45 years, he has provided cancer care and conducted research, including roles as a tenured faculty member in medical and radiation oncology at Stanford, Professor and Chair of Radiation Oncology at Harvard Medical School, and currently Senior Investigator and Associate Director of the Radiation Research Program at the National Cancer Institute (NCI). In recent years, he helped to establish the International Cancer Expert Corps (ICEC), which aims to increase capacity in developing countries to provide high-quality cancer care.

Ms. Crawford is a two-time cancer survivor and has been a tireless advocate for cancer patients and families for more than four decades. She helped found many cancer programs, culminating in 2013 when she co-founded Cancer CAREpoint, a nonprofit in Silicon Valley that provides free support to anyone impacted by cancer. She also helped lead an effort to build a “patient-focused” cancer center at Stanford University, where she was later named the founding chair of the Stanford Health Care’s Patient & Family Advisory Council.

Ellen L. Stovall Award Reception Details

The honorees will be recognized at the Stovall Award Reception in Washington, D.C. on November 14. The award presentation will feature videos highlighting the honorees and their work.

Stovall Award Reception

Wednesday, November 14, 2018

6:30 PM — 8:30 PM

Four Seasons Hotel
Washington, DC

For sponsorship and ticket information, please click here or call us at 301.650.9127.

Related Posts

https://www.canceradvocacy.org/nccs-news/nccs-ellen-l-stovall-award-reception-recognizes-two-individuals-advancing-patient-centered-cancer-care/

https://www.canceradvocacy.org/blog/nccs-presents-inaugural-ellen-stovall-award-douglas-w-blayney-md/

Stovall Award sq Logo Bl Ribbon

NCCS’ Ellen L. Stovall Award Reception Recognizes Two Individuals Advancing Patient-Centered Cancer Care

/in , , /by
Pat Coyne and Meg Gaines are presented with the 2017 Stovall Award

Left to right: Dr. Julia Rowland, Honoree Martha “Meg” Gaines, NCCS CEO Shelley Fuld Nasso, Honoree Patrick Coyne, and Dr. Thomas Smith at the 2017 Stovall Award Reception on October 19, 2017.

Silver Spring, MD – The National Coalition for Cancer Survivorship (NCCS) presented its second annual Ellen L. Stovall Award for Innovation in Patient-Centered Cancer Care last night in Washington, D.C. After a nationwide competition, a distinguished selection committee chose this year’s winners, Pat Coyne, MSN, of the Medical University of South Carolina and Meg Gaines, JD, of the University of Wisconsin at Madison. Mr. Coyne was nominated by Thomas J. Smith, MD, of Johns Hopkins University School of Medicine. Ms. Gaines was nominated by Julia H. Rowland, PhD, recently retired director of the Office of Cancer Survivorship at the National Cancer Institute.

Ellen L. Stovall Award for Innovation in Patient-Centered Cancer CareNamed for longtime CEO of NCCS and three-time cancer survivor Ellen L. Stovall, who died in 2016, the award aims to honor her memory and advocacy by annually recognizing individuals, organizations, or other entities that are innovators in improving cancer care. Applications for the 2018 Stovall Award will be accepted beginning February 1, 2018.

“Ellen Stovall set the bar in advocacy with her determination to improve cancer care for everyone,” said NCCS CEO Shelley Fuld Nasso. “Pat Coyne and Meg Gaines have dedicated their careers to making the lives of all those diagnosed with cancer better, and each is incredibly deserving of the Stovall Award. We were honored to have an outstanding set of nominees. I want to thank our sponsors and all the individuals who submitted nominations and served on the selection committee for making this year’s award program an incredible achievement. All of us at NCCS are excited to build on this success for next year’s award.”

“Receiving this award is humbling for me knowing how hard Ellen tirelessly fought for the needs of others,” said Pat Coyne. “It is an honor to be associated with her name, and all that she stood for to put the needs of patients at the center of cancer care. We have come a long way, but so much more work remains. I sincerely appreciate Dr. Smith, the selection committee, NCCS, and all those associated with the Stovall Award for this recognition.”

“I was privileged to know Ellen Stovall, and am honored to have my work recognized by the organization she started, the National Coalition for Cancer Survivorship,” said Meg Gaines. “Ellen paved the way for cancer survivors across the globe; her gentle but mighty hand will be felt for generations.”

Mr. Coyne, an advanced practice nurse, has devoted his career to the advancement of the field of palliative care. He is one of the founders of ELNEC (End-of-Life Nursing Education Consortium), which has educated more than 21,000 nurses in over 90 countries, and he has published over 100 papers on a variety of symptom management and policy issues.

Ms. Gaines is a lawyer by training, a cancer survivor, and one of the founders of the Center for Patient Partnerships at the University of Wisconsin. The Center trains students in the fields of law, medicine, nursing, pharmacy, and social work to provide advocacy to cancer patients. Interdisciplinary teams help cancer patients understand their diagnoses, get the information necessary to make critical treatment decisions, and support patients’ efforts to get the treatment they need.

# # #

Learn more about the Ellen L. Stovall Award for Innovation in Patient-Centered Cancer Care »

Read about Ellen’s life of advocacy »

Douglas Blayney Shelley Fuld Nasso and Jonathan Stovall w Award

NCCS Presents the Inaugural Ellen Stovall Award to Douglas W. Blayney, MD, FACP (Video)

/in , , , /by
The Ellen Stovall Award: Jonathan Stovall, Douglas W. Blayney, MD, and Shelley Fuld Nasso

From left to right: Jonathan Stovall, Douglas W. Blayney, and Shelley Fuld Nasso

At the National Coalition for Cancer Survivorship’s (NCCS) 30th Anniversary Reception on October 13, 2016, NCCS presented the inaugural Ellen Stovall Award for Leadership in Patient-Centered Care. The award was created to honor former NCCS CEO Ellen Stovall, who led the organization for more than twenty years and passed away in January 2016 from complications related to her cancer treatments.

The award recipient was Douglas W. Blayney, MD, FACP, past president of the American Society of Clinical Oncology (ASCO) and who worked closely with Ellen Stovall for many years. Together they helped initiate the ASCO Quality Symposium, which has become the leading cancer quality meeting in the world.

Shelley Fuld Nasso Remembers Ellen Stovall

NCCS CEO Shelley Fuld Nasso thanked the attendees to the NCCS 30th anniversary reception, many of them current and former NCCS staff and colleagues of Ms. Stovall, for their contributions to the field of cancer survivorship. “Everyone in this room today has helped in some way have an impact on our work over the past 30 years and on the lives of people with cancer,” Ms. Fuld Nasso said.

She continued, “As we commemorate this milestone in our history, we also, of course, have to recognize the devastating loss that we at NCCS felt, and all of us in the cancer community, when Ellen Stovall passed away earlier this year–our former CEO, dear friend, and mentor… Ellen left an indelible mark on all of us… She’s really our guiding light at NCCS and I often find myself thinking, ‘What would Ellen do?'” After a short video tribute to Ellen’s life and advocacy, Shelley invited Ellen Stovall’s son, Jonathan Stovall, on stage to present the award named in his mother’s honor.

Dr. Blayney Accepts the Ellen Stovall Award

In her introduction, Shelley Fuld Nasso highlighted the collaborative efforts of Dr. Blayney and Ms. Stovall. “Dr. Blayney did not shy away from Ellen’s demands that much more needed to be done to ensure access to patient-centered care, or her insistence that patient satisfaction with their cancer care really did matter. Instead, he was a dedicated partner in these efforts.” She continued, “When Ellen and Doug were working shoulder to shoulder on a wide range of cancer quality improvement efforts, they were pioneers. Not all their peers supported, or even saw the point of all their dogged efforts to improve quality.”

Dr. Blayney accepted the inaugural award and honored Ms. Stovall’s work and advocacy for cancer survivors in his remarks. “Ellen was a living reminder of cancer survivorship,” said Dr. Blayney. “She lived her life with purpose and never-failing grace. She articulated for so many audiences, the purpose of our work, and reminded us that it was always about the patient. I am honored with the Stovall award.”

Douglas W. Blayney, MD, FACP is a professor of medicine at the Stanford Comprehensive Cancer Center. His clinical interest is breast cancer, and his operational interests and research focuses on quality improvement in cancer care systems, improvement of the patient experience, and the optimum use of information technology to enhance these missions. He is past president of the American Society of Clinical Oncology (ASCO), and was the founding editor-in-chief of ASCO’s Journal of Oncology Practice.

The Ellen Stovall Award: 2017 and Beyond

At the reception, NCCS announced that beginning in 2017, the Ellen Stovall Award will be an annual, nationwide competition. It will be the first call to action that specifically urges cancer survivors and caregivers to nominate providers who are making dramatic improvements in how they care for cancer patients and their families. With recent changes in care towards value-based reimbursements and the Oncology Care Model, NCCS seeks to highlight providers who are proactively and successfully embracing patient-focused care that is recognized by the very patients they are serving. Dr. Blayney will serve as co-chair of an advisory committee to establish the award’s criteria and evaluate nominations.

# # #
Ellen Video PACT 1200px

Watch the Complete Video Recording of the Ellen Stovall Tribute Service

/in , , , /by

On February 24, 2016, a tribute to celebrate the life and legacy of Ellen Stovall was held at the Carnegie Institution for Science in Washington, D.C. Family, friends, and colleagues shared their touching memories about a woman who was dedicated to her family, a three-time cancer survivor, and a tireless advocate on behalf of all those touched by cancer. A video recording of the entire memorial service is embedded below. Please continue sharing your thoughts and remembrances about Ellen Stovall by signing her guestbook.

[embedyt] https://www.youtube.com/watch?v=agp3CIBbH3A&width=1089&height=614&centervid=1&vq=hd720&autohide=1&listType=playlist&list=PLyzl-T9rMBd3AZDdTjMKEbWW-LTQKWQUw&plindex=0&layout=gallery&gallery_style=carousel[/embedyt]

Memorial Program

Part One

Sandy Welton, Board Chair of NCCS, welcomes the crowd and reads a letter from Vice President Joe Biden
Barbara Hoffman, JD and Dr. Fitzhugh Mullan, founding members of NCCS
Dr. Richard Pazdur, FDA

Part Two

Dr. C. Norm Coleman, National Cancer Institute
U.S. Rep. Lois Capps (D-CA), Sponsor of The PACT Act
Elizabeth Goss, JD of Turner & Goss LLP

Part Three

“Ellen Stovall: One Person Can Make a Difference” Video Presentation
Sig Roos, cousin of Ellen
Julia Rowland PhD, Director, Office of Cancer Survivorship, NCI
Shelley Fuld Nasso, CEO of NCCS

Ellen headshot B

Vice President Joe Biden’s Tribute to Ellen Stovall’s Legacy

/in , /by

At yesterday’s moving tribute to Ellen Stovall, the following letter from Vice President Joe Biden was read to those in attendance. We wanted to be sure to share it with all of you.

Dear Friends:

Click to View the Letter Full-Size

It is with great sadness that I join you today in mourning the loss of Ellen Stovall—a beloved mother, spouse, daughter, sister, and a true champion in a fight that so many around the world face. It is far more appropriate, though, to join you in celebrating the life and work of such a champion.

We all know someone who has had cancer or is fighting to beat it. Ellen’s long-fought battle demonstrates the perseverance that we encounter in so many survivors, but her battle did not end with remission, or even survivorship. Ellen continued to fight for change in a system that needed refocusing, placing the patient at the center of cancer care and research. Her vigorous embrace of this cause and unwavering courage in the face of a difficult challenge has given millions of patients, survivors, and families the hope and comfort they deserve.

Ellen Stovall undertook ambitious goals with great leadership and integrity. A moonshot to cure cancer is only as good as its fiercest advocates, and in Ellen, we will remember these heroic qualities that truly set her apart and inspire us to persist in this fight. Ellen made it her life’s work to ensure the most important voices aren’t lost in the mix and from personal experience, I know how important that is. Her legacy is one of genuine, tangible results that positively transformed the way cancer care is delivered.

As we work to solidify a global commitment to end cancer as we know it today, let us do so with Ellen’s sense of purpose and priority.

Sincerely,

Joseph R. Biden, Jr.

ASCO Announces Creation of Ellen L. Stovall Award

/in , , /by
Ellen L. Stovall

Ellen L. Stovall

The American Society of Clinical Oncology (ASCO) today announced the creation of the Ellen L. Stovall Award and Lecture for Advancement of Cancer Survivorship Care, intended to recognize and promote the work of pioneers and leaders in the growing field of survivorship. The annual award will honor Ellen’s contributions to the cancer survivorship movement and continue the legacy of her pioneering work by recognizing extraordinary individuals who have made multiple, significant, and enduring contributions to cancer survivorship care. The first award will be presented at the 2017 Cancer Survivorship Symposium, taking place January 27-28 in San Diego, California.

“Ellen Stovall was a passionate advocate for the unique needs of cancer survivors,” said ASCO Chief Medical Officer Richard L. Schilsky, MD, FASCO. “As a long-term cancer survivor herself, she understood the concerns and fears of cancer survivors, the chronic disabilities they experience and the impact of surviving cancer on a person’s ability to return to a normal, productive and satisfying life after cancer. Through her work with NCCS, Ellen worked tirelessly to draw attention to and address the medical, psychological, and societal challenges faced by cancer survivors and to ensure they have access to the support and services they need.”

“We at NCCS are deeply grateful to ASCO for creating this award in Ellen’s honor, and for convening the oncology and primary care communities to advance survivorship care,” said NCCS Chief Executive Officer Shelley Fuld Nasso. “Ellen would be pleased to see the collaboration between these two important disciplines and the focus on expanding the evidence base for survivorship care.”

Further Reading:

“ASCO Remembers Patient Advocate Ellen L. Stovall, FASCO” »

Remembering Ellen Stovall

Posts not found

National Coalition for Cancer Survivorship
8455 Colesville Road  |  Suite 930  |  Silver Spring, MD 20910
877-NCCS-YES  |  info@canceradvocacy.org
Privacy Policy  |  Terms and Conditions

Copyright © 1995-2020 by the National Coalition for Cancer Survivorship
National Coalition for Cancer Survivorship, NCCS, Cancer Survival Toolbox, and related Logos are registered in the United States as trademarks of the National Coalition for Cancer Survivorship.